LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

Search

Guardant Health Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

87.81 -2.65

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

87.25

Max

90.33

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-36M

-128M

Pardavimai

16M

281M

Pelnas, tenkantis vienai akcijai

-0.5

Pelno marža

-45.684

Darbuotojai

2,490

EBITDA

-37M

-119M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+45.37% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-04-29

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-1.7B

12B

Ankstesnė atidarymo kaina

90.46

Ankstesnė uždarymo kaina

87.81

Naujienos nuotaikos

By Acuity

50%

50%

147 / 351 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

Guardant Health Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-11 19:18; UTC

Pagrindinės rinkos jėgos

Stryker Shares Down After Cyberattack Tied to Iran-Linked Group

2026-03-11 23:54; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-11 23:54; UTC

Rinkos pokalbiai

Nikkei May Decline on Energy Costs Concerns -- Market Talk

2026-03-11 23:51; UTC

Rinkos pokalbiai

Gold Falls as Rising Oil Prices Spur Inflation Worries -- Market Talk

2026-03-11 23:41; UTC

Rinkos pokalbiai

REA Bull Sees Potential Upside to Yield Guidance -- Market Talk

2026-03-11 23:37; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Oil Futures Rise Amid Ongoing Middle East Conflict -- Market Talk

2026-03-11 23:17; UTC

Svarbiausios naujienos

Front-Month WTI Crude Oil Futures Rise 5.5% to $92.05/bbl

2026-03-11 23:17; UTC

Svarbiausios naujienos

Front-Month Crude Oil Futures Rise Amid Ongoing Middle East Conflict

2026-03-11 22:29; UTC

Rinkos pokalbiai

Australia Shares Set to Fall in Early Trade -- Market Talk

2026-03-11 21:47; UTC

Uždarbis

Liontown Resources: Market Tailwinds Strengthening Outlook

2026-03-11 21:46; UTC

Uždarbis

Liontown Resources: 4 Mln Ton Per Annum Expansion Study Underway

2026-03-11 21:45; UTC

Uždarbis

Liontown Resources Says FY26 Guidance Unchanged

2026-03-11 21:45; UTC

Uždarbis

Liontown Resources 1H Unit Operating Costs A$985/Ton

2026-03-11 21:44; UTC

Uždarbis

Liontown Resources 1H Underlying Ebitda Loss A$7.7 Million

2026-03-11 21:43; UTC

Uždarbis

Liontown Resources 1H Revenue A$207.5 Million

2026-03-11 21:43; UTC

Uždarbis

Liontown Resources 1H Net Loss A$184 Million

2026-03-11 21:12; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Rival Strikes Deal With Google in Battle for AI Content -- Barrons.com

2026-03-11 21:10; UTC

Uždarbis

Vista Gold FY25 Loss $7.5M >VGZ

2026-03-11 21:10; UTC

Uždarbis

Vista Gold FY25 Loss/Shr 6c >VGZ

2026-03-11 20:50; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Basic Materials Roundup: Market Talk

2026-03-11 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-03-11 20:27; UTC

Įsigijimai, susijungimai, perėmimai

Papa John's Draws Fresh Takeover Interest -- 2nd Update

2026-03-11 20:26; UTC

Uždarbis

These Stocks Are Today's Movers: Oracle, UniFirst, Fair Isaac, Nebius, AeroVironment, Campbell's, and More -- Barrons.com

2026-03-11 20:19; UTC

Svarbiausios naujienos

The Strait of Hormuz Could Take Weeks -- Even Months -- to Reopen, Military Experts Say -- Barrons.com

2026-03-11 20:15; UTC

Uždarbis

This Physical AI Stock Jumped on Earnings. The Robots Are Coming. -- Barrons.com

2026-03-11 20:12; UTC

Svarbiausios naujienos

Stock Market Today: Oil Prices Push Higher Despite IEA Oil Release Headline -- WSJ

2026-03-11 19:31; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Oil Futures Gain Despite IEA's Planned Release of Reserves -- Market Talk

2026-03-11 19:01; UTC

Rinkos pokalbiai
Svarbiausios naujienos

U.S. Natural Gas Gains With Middle East Conflict in View -- Market Talk

2026-03-11 18:59; UTC

Įsigijimai, susijungimai, perėmimai

Berkshire's Deal for Occidental Chemicals Unit Is a Winner as Chemical Stocks Surge -- Barrons.com

2026-03-11 18:43; UTC

Svarbiausios naujienos

Chubb Named Lead Insurer for U.S. Plan to Protect Oil Tankers in Strait of Hormuz -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Guardant Health Inc Prognozė

Kainos tikslas

By TipRanks

45.37% į viršų

12 mėnesių prognozė

Vidutinis 132.58 USD  45.37%

Aukščiausias 175 USD

Žemiausias 110 USD

Remiantis 21 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Guardant Health Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

21 ratings

20

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

38.86 / 47.41Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bullish Evidence

Rinkos nuotaikos

By Acuity

147 / 351 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Guardant Health Inc

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research; and with ConcertAI to form first data-as-a-service that integrates clinical and tumor profiling data to accelerate cancer therapy research and development. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
help-icon Live chat